Cambria Investment Management »

Eliem Therapeutics shares owned by Cambria Investment Management

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Cambria Investment Management from 13F filings

Historical chart of Cambria Investment Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Cambria Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Cambria Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $993k 76k 13.04

More positions owned by Cambria Investment Management

Cambria Etf Tr Cambria Fgn Shr (FYLD)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Cambria Etf Tr Global Value Etf (GVAL)
Cambria Etf Tr Value Momentum (VAMO)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Tidal Trust Ii Camb Che Pur Etf (MFUT)
Cambria Etf Tr Gbl Real Est Etf (BLDG)
Spdr Series Trust State Stret Spdr (CERY)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Apple (AAPL)
Cambria Etf Tr Tacti Yield Etf (TYLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Valero Energy Corporation (VLO)
J Global (ZD)
Hf Sinclair Corp (DINO)

View all positions for Cambria Investment Management

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics